ti,901.0001. 8V1
ti,901.0001. 8V1
HARRY FISCH. M.D. tel: (212) 879-0800 fax: (212) 988-1634
FACSIMILE TRANSMISSION
Date: 7 \COIL
6 re I 11 PLEASE DELVER ATTACHED MESSAGE
TO: Z-e--f-C`Pt e
FAX #: TEL #:
Regarding:
Number of pages (including cover
Remarks: page):
4£9L886ZLZL LPsu H kuLE SO 9 LOZ 60 abed
EFTA01733939
bity/ I, • tlr, • ...YON. ,••••••••,..Yinavill trollwit Max +NW br,rne
trim Mar Noel tempi' v.' AO t!, Miramar. L ism m.,:a.W.2.ttiat,rat. irrar: M.Priabt
IDat ammardar irararammilimatoraniaramitetri iraris 2.0arar bar L Hit II 44, Oiirri d to tar limbrutrOwnIkbh I/Its
banns, tow ,~3110PM,I1,60 , etmbecw. Opplanit VW) 801.12.0.70 •
EFTA01733940
kg 09 2016 0937FII Harry Hach 12129861634 e
teetireni A .,L'422
re-Y-nernA"
EFTA_R1_00010816
EFTA01733941
L490L000 -fti-V133
FINAL REPORT MANJA.IMWAII"\WAAAI'ml
- EPSTEIN,
)D08:01/29/1953
Address:3
w NEW YORK,
P: (212)
, LABORATORIES
n FISCH, HARRY
0 HARRY FISCH, M.D.
944 PARK AVENUE
New York, NY 10028
Acct I: (C1720-1) Si 0 P: (212) 879-0800
P, JEFFREY
Age:63 Y Sex:/1
E 71ST STREET
NY 10021
772-9415 S Specimen ID: 105819158
A Date Of Report: 07/23/2016
M Date Collected: 07/20/2016
Time Collected: 08:52 i)Date Received: 07/20/2016 L Time Received: 23:20
C
North America Eastern Time
C_INICA'_ REPOt:
Clinical Abnormalities Suarnary: ;may ra :ortaw ae aoname [ewes. eau ve toots may rot babe aonnat laps muse 'mew tome report)
Creatinine 0.62 LO BUN/Creat Ratio
Cholesterol 210 HI Triglycerides
HDL as % of 13 Chol/HDL Ratio
Cholesterol
MDC 35.2 HI
Hemoglobin A1c 5.9 HI 33.9 HI ALT 42 HI
950 HI HDL CHOL., DIRECT 28 LO
7.5
NON FASTING
CHEMISTRY
-t"'- .syk'ilitirga,:a.hiata,.. ?,*-V,TirL:T.1 -,AAK::£11;02.9);,:n).::::::2447.1AOM4. ,total Protein 7.0 5.9-8.4 g/dL 6.7 .01/27/2016
,Albumin 4.7 3.5.5.2 g/dL 4.2 01/27/2916
Globulin 2.3 1.7-3.7 g/dL 2.5 01/27/2016
A/G Ratio 2.0 1.1-2.9 1.7 01/27/2016
Glucose 93 70-99 mg/dL 99 01/27/2016
Sodium 140 135-147 msol/L 141 01/27/2016
rE/W Potassium 4.6 3.5-5.5 esol/L 4.2
Chloride 97 96-188 mmol/L 102 01/27/2016
CO2 24 22-29 msol/L 26 01/27/2016
BUN 21 8-23 mg/dL 22 01/27/2016
Creatinine 0.62 LO 6.89-1.30 mg/dL 1.11 81/27/2016
e-GFR 106 >orm68 mi/min 70 01/27/2816
e-GFR, African American 123 x)rm60 et/min 81 01/27/2016
BUN/Crest Ratio 33.9 HI 10.9-28.0 19.8 01/27/2016
Calcium 9.8 8.6.18.4 mg/dL 9.8 01/27/2016
Uric Acid 7.4 3.4-8.5 mg/dL 7.5 81/27/2016
Iron 96 45-160 ug/dL 75 01/27/2016
Bilirubin, Total 0.6 <1.2 mg/dL 0.5 81/27/2816
LD 286 135-225 U/L 171 01/27/2016
Alk Phas 70 40-156 U/L 43 01/27/2016
AST 32 <40 U/L 29 01/27/2016
Phosphorus 3.8 2.7.4.5 mg/dL 3.4 01/27/2016
ALT 42 HI <41 U/L 29 01/27/2016
GGTP 19
C:4RDT0',./SClili,R TPT0c-
,
Cholestero 220 HI 10-71 U/L
:
<200 •L 18
„.
143 81/27/2016
(
01/27/2016
Triglycerides 958 HI
ROTE: The result for Triglycerides has been confirmed <150 mg/di 459 HI
by repeat analysis. 01/27/2016
HDL CHOL., DIRECT 28 LO >40 mg/dL 24 LO
HDL as % of Cholesterol 13
Evaluation: MOVE AVG.(HODERATE RISK) 101/27/2016
>14 X ! 17 01/27/2016
Chol/HDL Ratio 7.5 <7.4 6.0 81/27/2016
BioReference Laboratories, Inc.
481 tdward H. Ross Dr I Elmwood Park, N2 07407 I (800) 219-5227 lames Heisberger, N.D. Clinical Page 1 of 6
Laboratory Director Printed 07/25/2016 07:01
a6ed 4£91926ZI.a. L-Pstd kueH WdL£SO 9I.62 60 5rY
EFTA01733942
9490L000 L2!—V.Ld3
FINAL REPORT J-11,01NA,w1kwl 1/44.1%.As
e ''W
LABORATORIES
• I ',EPSTEIN, • .3 D08:01/20/1953
Address:9
NEW YORK,
P: (212)
t ...e
Ti
—s.t. JEFFREY
Age:63 Y Sex:M
E 71ST STREET
NY 10021
772-9416 RISCH, HARRY
, HARRY FISCH, M.D.
C 944 PARK AVENUE
New York, NV 10028
T Acct *: (C1720-1) SI
P: (212) 879-0800 . s Specimen ID: 105819158
A Date Of Report: 87/23/2016
M Date Collected: 07/20/2016
Time Collected: 08:52
PDate Received: 07/20/2016
lTime Received: 23:20
E
North America Eastern Time
CLINICAL REPORT
$ a .1 ...40 .,
Evaluation: ABOVE AVG.(MODERATE RISK) $4: :10044 40072‘111dIR - IWO ' ,r,iir
LDL/HDL Rat10 Can't Calc <3.56 I Can't Calc 01/27/2016
LDL Cholesterol Can't Calc
NOTE: Unable to calculate LOL due to a Triglyceride .evel <100 mg/dl.
of greater than 400 mg/dL. Can't Calc 01/27/2016
VLDL, CALCULATED Can't Calc 7-32 mg/dL Can't Calc 01/27/2016
Can't Calc: One or more components was outside the measurable
range. We are unable to calculate.
HENA1OLOGY
Wit'-t--;:!;-?:;It•;.:•14: • ' - ,,,:14.4(4n _. 4., ' ...,:it..t.:,142:',:: -31.:.; • • • ....3LX:S1,„Z WBC 7.79 3.66-11.99 x10(3)/uL 7.12 01/27/2816
RBC 5.18 4.20-5.90 x10(5)/ut 4.96 01/27/2016
HGO 15.4 12.3-17.0 gm/di. 14.3 01/27/2016
HCT 43.8 39.3-52.5 % 41.3 01/27/2016
MCV 84.6 80.0-100.0 fL 83.3 01/27/2016
MCH 29.7 25.0-34.1 pg 28.8 01/27/2016
MCHC 35.2 HI 29.0-35.0 gm/dL 34.6 01/27/2016
ROW 14.8 10.9-16.9 % 13.9 01/27/2016
POLYS 45.8 36.0-78.0 % 49.2 01/27/2016
LYMPH5 39.0 12.0-48.0 % 36.2 01/27/2016
MON05 8.9 0.0-13.0 % 7.6 01/27/2016
E05 5.4 0.0-8.0 X 6.5 02/27/2016
BASOS 0.6 0.0-2.0 X 0.4 01/27/2016
IMMATURE GRANULOCYTES 0.0 0.0-1.6 % 0.1 91/27/2016
PLATELET COUNT 281 144-400 x10(3)/uL 222 01/27/2016
MPV 8.9
NOTE: New reference ranges for WBC and Absolute coun.s 8.2-11.9 fL 9.5
are effective 4/2S/2016. 01/27/2016
PT Ttf?
Test Not Performed: Specimen REJECTED for testing due 9.1-11.9
to GROSS LIPEMIA. sec 10.1 01/27/2016
INTR.NORM.RATIO(INR) TNP 2.00-3.00
sec 0.97 10 01/27/2016
PTT TNP 23.6-31.6 26.5 01/27/2016
URINIILYSIS
itiglaShiiiiS,azo.L.:-. ,:ilktittabittLT1;$' 4' ' Color YELLOW YELLOW,
STRAW, AMBER
Character CLEAR CLEAR
Specific Gravity Ur 1.025 1.003 -
1.030
pH Urine 6.5 5.0 - 8.0
Protein, Urine NEGATIVE NEGATIVE
Glucose, Urine NEGATIVE NEGATIVE
Ketone, Urine NEGATIVE NEGATIVE
Urobilinogen Urine 0.2 0.2 - 1.0 mg/dL
sioReference Laboratories, Inc.
481 Edward H. Ross Dr I Elmwood Park, N3 07407 I (800) 2: lames Weisberger, M.D. Clinical Page 2 of 6
9-5227 Laboratory Director Printed 07/25/2016 07:01
g abed 4£9L886ZLZ1 LIDsH /URN Wd8£:50 9L02 60 6rr
EFTA01733943
6480 L000L8Thild3
Dieference LABORATORIES
O gISCH, HARRY
c HARRY FISCH, M.D.
C 944 PARK AVENUE
New York, NY 10028
Acct It: (C1720-1) 51 0 P: (212) 879-0800
P. EPSTEIN,
DOB:01/20/1953
Address:, yy
e NEW YORK,
P: (212)
.'
.4
4 JEFFREY
Age:63 Y5ex:M
E 71ST STREET
NY 10021
772-9416 c Specimen ID: 105819158
A Date Of Report: 07/23/2816
‘.1 Date Collected: 07/20/2016
Time Collected: 08:52 P Date Received: 07/20/2016
' Time Received: 23:20
E
North America Eastern Time
Cr_INIC:4•1 REPORT
....ThiilitZYA•fgOi c.i4;:nt
Bilirubin, Urine NEGATIVE • NEGATIVE eu
Blood, Urine NEGATIVE NEGATIVE
Nitrites Urine NEGATIVE NEGATIVE
Leukocyte Esterase NEGATIVE NEGATIVE
Crystals Urine NONE NONE
Crystal Amt. Urine NONE NONE
WBC, Urine 0-4 0-4 PER HPF
RBC, Urine NONE SEEN NONE SEEN PER HPF
Epithelial Cells, Ur NONE FEW
Cast, Hyaline, Urine 0-4 0-4 PER LPF
Cast, Granular, Ur NONE SEEN 0-1 PER LPF
Cast, RBC, Urine NONE SEEN 0-1 PER LPF
Bacteria, Urine NONE FEW
VITCRORTOECCN
kigit...,t;ai;V.44 -4:„.„1 . y
CULTURE, URINE NO GROWTH
SITE: URINE
nisciLLPNLcus
....:-.4,+.?..,*,24:Tifd4W1816 .4,L,-,.. NO GROWTH
•,n'?..-.. ......- :.."*.'xr —" C ,:' 7.-'," ir/' --" Hemoglobin Alc 5.9 HI
HEMOGLOBIN A1c AND eAG REFERENCE RANGES
Alc(%) DIABETES CATEGORY*
<5.7 Normal (nos
5.7-6.4 Increased risk
.>6.5 Consistent
Aic(%) eAG(ESTimATED AVERAGE
6 126
7 154
8 103
9 212
10 240
11 269
12 298
'recommended ranges -American Diabetes
NOTE: Hemalysis, rare hemoglobin variants and thalavemia <5.7 6.0 HI 101/27/2016
-diabetic)
of diabetes
with diabetes
PLASMA GLUCCGE)(mg/dL)
Association(2010)
major may affect glycemic results.
TSH TNP
Test Not Performed: Specimen rejected for testing due
hemolysis. 0.178-4.530 uIU/ml. i 1.790 101/27/2016
to moderate or marked
Thyroxine(T4) TNP
Test Not Performed: Specimen rejected for testing due 4.9-12.9 ug/dL
to moderate or marked 6.3 101/27/2016 FINAL REPORT
BioReference Laboratories, Inc.
481 Edward N. Ross Dr I Elmwood Park, N3 07407 I (800) 2 lames Weisberger, A.D. Clinical Page 3 of 6
-5227 Laboratory Director Printed 87/25/2016 07:01
g abed 4£9L886ZLZL LPsY AlleH Wd6E:g0 9LOZ 60 6w
EFTA01733944
OSSOL000 1.8Thild3
BioReference LABORATORIES
IIIII OIscm, HARRY
HARRY FISCH, M.D.
944 PARK AVENUE
New York, NY 10028
Acct It: (C1720-1) Si
P: (212) 879-0800
herolysis. EPSTEIN, 3EFFREY
D08:01/20/1953 Age:63 V Sex:M
Address:9 E 71ST STREET
NEW YORK NY 10021
P: (212) 772-9416
T3 Uptake(T3U) TNP 24.3-39.0 %
Test Not Performed: Specimen rejected for testing due to moderate or marked
hemolysis. FINAL REPORT
S
A
td
L
F Specimen ID: 105819158
Date Of Report: 07/23/2016
Date Collected: 07/20/2016
Time Collected: 08:52
Date Received: 07/20/2016
Time Received: 23:20
North America Eastern Time
29.3 101/27/2016
THYROXINE, FREE(FT4) TNP 0.80-1.73 ng/dL
Test Not Performed: Specimen rejected for testing dut to moderate or marked
heaolysis.
FREE T4 INDEX TNP 1.5-3.8
T3(THYRONINE), TOTAL TNP 72-180 ng/dL
Test Not Performed: Specimen rejected for testing due to moderate or marked
hemolysis.
PSA Total TNP <4.00 ng/ml.
Test Not Performed: Specimen rejected for testing due to moderate or marked
hemolysis. 101/27/2016
1.8 101/27/2016
127 01/27/2016
NOTE: The PSA assay should not be the only test used for diagnostic purposes.
Additional evaluation using ORE, ultrasound, TUR or similar procedures may
be used for this purpose. Predictions of disea e recurrence should not be
based solely upon values obtained from serial PSA values obtained on the
patient.
NOTE: Values obtained with different assay methods or kits cannot be
used interchangeably.
NOTE: Results cannot be interpreted as absolute evidence of the presence or
absence of malignant disease.
ASSAY INFORMATION: Method Electrochemiluminescence Immunoassay (Roche Diagnostics)
PSA, FREE TNP Not Estab. ng/mL
Test Not Performed: Specimen rejected for testing due to moderate or marked
hemolysis. 0.70 101/27/2016
NOTE: Results cannot be interpreted as absolute evidence of the
presence or absence of malignant disease. values obtained
with different assay methods or kits cannot be used
interchangeably.
ASSAY INFORMATION: Method ElectrochemilumineSCence IamunOaSSay
(Roche Diagnostics).
% FREE PSA TNP
FREE PSA RISK ASSESSMENT 0.33 T01/27/2016
See Below %
The probability of prostate cancer for men with non-suspicious DRE results, by
age group, using PSA values between 4.000 and 10.080 ng/mL and percent FREE PSA
values is sumarized in the table below:
BioReference Laboratories, Inc. lames Weisberger, N.D.
481 Edward H. Ross Dr I Elmwood Park, NI 07407 I (800) 2:9-5227 Laboratory Director 47 161/27/2016
Clinical Page 4 of 6
Printed 07/25/2016 07:01
L abed 4E9LS86ZLZI WSJ £ueH kHOP:SO 9142 60 6ny
EFTA01733945
LS801.000laVid3
BioReference ?...-4cS ZSI.er LABORATORIES
.iEPSTE/N,
9 '1000:01/20/1953
4address:1
NEW YORK
P: (21t
—ji JEFFREY
Ago:63 YSOX:M
E 71ST STREET
NY 10021
) 772-9416 FINAL KEPOKI
6
• FISCH, HARRY
HARRY FISCH, M.D.
944 PARK AVENUE
New York, NY 10028
Acct 0: (C1720-1) Si
P: (212) 879-0800 5 Specimen ID: 105819158
4 Date Of Report: 07/23/2016
Date Collected: 07/20/2016
Time Collected: 08:52
PDate Received: 07/20/2016 I Time Received: 23:20
F
T North America Eastern Time
CLINICAL REPORT
OF CANCER . PROSABILIIY
%free PSA (50-59 yrs) (60-69 yrs) (>or=70 yrs)
cor.10 49.2% 57.5% 64.5%
11-18 26.9% 33.9% 40.8%
19-25 18.3% 23.9% 29.7%
>25 9.1% 12.2% 15.8%
'probability of finding prostate cancer by need e biopsy
NOTE: Calculation of percent FREE PSA may not be pos ible when the value for
TOTAL PSA is in the low mammal range. These gu delines are for assays
performed using the Roche E602 immunoassay syS em.(8/2015;V8.0)
TESTOSTERONE, TOT.,S. TNP 193.0-740.0 ng/dL 296.0 101/27/2016
Test Not Performed: Specimen rejected for testing due
hemolysis. to moderate or marked
TESTOSTERONE, BIOAVAIL. TNP 72.0-460.0 ng/dL 183.8 01/27/2016
SEX HORM.BIND.GLOB. TNP 10-57 nmol/L 18 01/27/2016
Test Not Performed: Specimen rejected for testing due
hemolysis. to moderate or marked
FREE TESTOSTERONE TNP 30.00-150.00 pg/mt 80.18 101/27/2016
LH TNP 1.7-8.6 mIll/ml 6.8 01/27/2016
Test Not Performed: Specimen rejected for testing due
hemolysis. to moderate or marked
FSH TNP 1.5-12.4 mIU/mt fl6.8 01/27/2016
Test Not Performed: Specimen rejected for testing due
hemolysis. to moderate or marked
PROLACTIN, SERUM TNP 4.0-15.2 ng/mL 3.0 LO 101/27/2016
lest Not Performed: Specimen rejected for testing due
hemolysis. to moderate or marked
ESTRADIOL INF, 7.02-49.06 pg/ml 48.93 01/27/2016
Test Not Performed: Specimen rejected for testing due
hemolysis. to moderate or marked
FIBRINOGEN TNP 176-441 mg/a 276
DIHYDROTESTOSTERONS(7) 146.0 106-719 pg/m1 278.0 101/27/2016
01/27/2016
Reference Intervals for Males age 20 years and above:
106.0-719.0 pg/mL
Analysis by High Performance Liquid Chromatography/
TandemMass Spectrometry (LC-MS/MS)
(7)
Performed by: National Medical Lab
2300 Stratford Ave.
Willow Grove, PA 19090
eioeeference Laboratories, Inc.
481 Edward H. Ross Dr I Elmwood Park, Nl 07467 I (800) Jones Weisberger, M.D. Clinical Page 5 of 6
-5227 Laboratory Director Printed 07/25/2016 07:01
8 abed VE9L886ZLZL ku8H l'HOVS0 9LOZ 60 find
EFTA01733946
📷 Images in this document (8 detected; 6 largest described)
AI-generated factual descriptions of embedded images (llava:13b). These are searchable across the corpus.
[Image 1] The image shows a handwritten note on a piece of paper. The note contains various scribbles and doodles, with some words and phrases that are partially obscured or difficult to decipher due to the handwriting style. There are also some circles drawn on the paper, possibly indicating areas of importance or interest. The paper appears to be a standard lined notebook paper, and there are no visible n
[Image 2] The image shows a document that appears to be a financial statement or an invoice. It contains a table with various columns, including dates, descriptions, quantities, unit prices, and totals. The document is printed on a standard letter-sized paper and is in black and white. The visible text includes numerical figures and descriptions of items or services listed, but the specific details are not
[Image 3] The image shows a document that appears to be a financial statement or report, possibly from a company or organization. The document is structured with columns and rows of numerical data, which could represent financial figures such as income, expenses, or other accounting data. There are headers at the top of the document, and the bottom section includes a footer with a date and possibly a page n
[Image 4] The image shows a document that appears to be a financial statement or report. It contains tables with numerical data, possibly related to income, expenses, or financial transactions. The document is structured with columns and rows, and there are visible names, dates, and numerical figures. The text is too small to read in detail, but it seems to be a formal document with a header and footer that
[Image 5] The image shows a document that appears to be a passport or travel document. It contains various fields filled out with information, including the name, date of birth, nationality, and other personal details. There is also a photograph of the individual, which is typically used for identification purposes. The document has a visible watermark or security feature, indicating it is a government-issu
[Image 6] The image shows a document that appears to be a financial statement or an invoice. It contains various columns with numerical figures, which are likely to represent expenses or income. The document is structured with headers and footers, typical of financial reports. There are no visible names, dates, places, or logos that can be confidently described. The document is a black and white scan, and t